Introduction
Professor Shen Kunwei (沈坤炜) is a senior breast cancer surgeon and Deputy Chief of Breast Surgery at Fudan University Shanghai Cancer Center (FUSCC) — China's most prestigious cancer center. With decades of clinical experience and a distinguished record in breast cancer surgery, Professor Shen is widely recognized as one of China's leading breast cancer surgeons. His expertise spans the full spectrum of breast cancer surgical management, with particular distinction in breast-conserving surgery, oncoplastic breast surgery, hereditary breast cancer management, and sentinel lymph node biopsy. Professor Shen is especially known for his expertise in BRCA-related breast cancer and high-risk breast cancer management. International patients seeking expert breast cancer surgery in Shanghai consistently regard Professor Shen as a premier choice.
Academic Distinctions & Leadership
- Deputy Chief of Breast Surgery, Fudan University Shanghai Cancer Center (FUSCC)
- Professor of Surgery, Fudan University Shanghai Medical College
- Member, Chinese Anti-Cancer Association, Breast Cancer Committee
- Hereditary Breast Cancer Committee Member, Chinese Anti-Cancer Association
- Member, Chinese Society of Breast Surgery
- Editorial Board Member, multiple Chinese and international breast cancer journals
- Recipient, multiple national and Shanghai municipal science and technology awards
- Visiting fellow at leading breast cancer centers internationally
Specializations & Expertise
Breast Cancer Surgery
- Breast-conserving surgery (lumpectomy) with oncoplastic techniques
- Nipple-sparing mastectomy
- Skin-sparing mastectomy
- Total mastectomy
- Modified radical mastectomy
- Sentinel lymph node biopsy (SLNB)
- Axillary lymph node dissection
- Surgery after neoadjuvant chemotherapy or targeted therapy
- Surgery for locally advanced breast cancer
Hereditary & High-Risk Breast Cancer
- BRCA1/2 mutation carriers — risk-reducing mastectomy
- Risk-reducing salpingo-oophorectomy coordination
- High-risk breast lesion management (LCIS, ADH)
- Genetic counseling coordination
- Surveillance and chemoprevention strategies
- Contralateral prophylactic mastectomy
Oncoplastic & Reconstructive Breast Surgery
- Immediate breast reconstruction after mastectomy
- Implant-based breast reconstruction
- Autologous breast reconstruction coordination
- Oncoplastic volume displacement and replacement techniques
- Nipple and areola reconstruction
- Contralateral breast symmetrization
Special Breast Cancer Populations
- Young women with breast cancer
- Pregnancy-associated breast cancer
- Male breast cancer
- Elderly patients with breast cancer
- Bilateral breast cancer
Clinical Excellence & Innovation
Professor Shen Kunwei has performed thousands of breast cancer surgeries throughout his distinguished career, with a particular reputation for excellence in hereditary breast cancer management and oncoplastic surgery. He is one of China's leading authorities on BRCA-related breast cancer and has established comprehensive hereditary breast cancer programs at FUSCC.
- Hereditary Breast Cancer Pioneer: One of China's foremost experts in BRCA1/2-related breast cancer management, including risk-reducing surgery and surveillance strategies
- Oncoplastic Surgery Excellence: Advanced oncoplastic techniques achieving excellent aesthetic outcomes while maintaining oncological safety
- Breast Conservation Advocate: Strong commitment to breast-conserving surgery for appropriate candidates, maximizing quality of life
- Young Patient Expertise: Specialized experience managing breast cancer in young women, including fertility preservation coordination and pregnancy-associated breast cancer
- Neoadjuvant Therapy Integration: Expert in optimizing surgical timing and approach after neoadjuvant chemotherapy or targeted therapy
Research & Academic Contributions
Professor Shen is one of China's most prolific breast cancer researchers with numerous peer-reviewed publications in leading Chinese and international oncology journals. His research focuses on hereditary breast cancer, oncoplastic surgery outcomes, breast cancer in young women, and neoadjuvant therapy surgical management.
Major research contributions include:
- BRCA1/2 mutation prevalence and clinical characteristics in Chinese breast cancer patients
- Risk-reducing surgery outcomes in BRCA mutation carriers
- Oncoplastic surgery techniques and long-term aesthetic outcomes
- Breast cancer in young Chinese women — clinical features and outcomes
- Surgical management after neoadjuvant chemotherapy
Hospital Affiliation
Fudan University Shanghai Cancer Center (FUSCC)
270 Dongan Road, Xuhui District, Shanghai 200032
Fudan University Shanghai Cancer Center is China's most prestigious and comprehensive cancer center. The Breast Surgery Department — where Professor Shen practices alongside Chief Professor Wu Jiong — is the largest and most respected breast cancer surgery program in China, featuring:
- Highest-volume breast cancer surgery program in China
- Multidisciplinary breast cancer team (MDT)
- Hereditary breast cancer clinic with genetic counseling
- Comprehensive breast imaging center
- Dedicated breast pathology team with molecular profiling
- Breast cancer clinical trials and research programs
- International patient services with English-speaking coordinators
Patient Care Philosophy
- Personalized Cancer Care: Every surgical plan tailored to tumor biology, genetic risk, patient anatomy, and personal preferences
- Hereditary Risk Management: Comprehensive approach to BRCA and other hereditary breast cancer syndromes
- Breast Conservation First: Strong preference for breast-conserving surgery when oncologically safe
- Body Image & Quality of Life: Committed to minimizing the physical and psychological impact of breast cancer surgery
- Multidisciplinary Approach: All cases reviewed by a comprehensive MDT
- Evidence-Based Practice: All decisions guided by the latest international breast cancer guidelines
Why Choose Professor Shen Kunwei?
- Hereditary Breast Cancer Authority: One of China's foremost experts in BRCA-related breast cancer and risk-reducing surgery
- Oncoplastic Surgery Expert: Advanced techniques preserving breast aesthetics while achieving oncological safety
- Young Patient Specialist: Extensive experience with breast cancer in young women including fertility considerations
- China's Premier Cancer Center: Access to FUSCC's comprehensive multidisciplinary breast cancer program
- Cost-Effective Excellence: Breast cancer surgery costs in Shanghai are typically 60-80% lower than in the US or Europe
- Proven International Track Record: Trusted by patients from around the world
Conditions Treated
Breast Cancer
- Early-stage breast cancer (Stage I and II)
- Locally advanced breast cancer (Stage III)
- HER2-positive breast cancer
- Triple-negative breast cancer
- Hormone receptor-positive breast cancer
- BRCA1/2-associated breast cancer
- Ductal carcinoma in situ (DCIS)
- Bilateral breast cancer
- Pregnancy-associated breast cancer
- Male breast cancer
High-Risk Conditions
- BRCA1/2 mutation carriers
- Other hereditary breast cancer syndromes (PALB2, CHEK2, ATM)
- Strong family history of breast cancer
- Atypical ductal hyperplasia (ADH)
- Lobular carcinoma in situ (LCIS)
International Patient Services
China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking breast cancer surgery with Professor Shen Kunwei at Fudan University Shanghai Cancer Center.
Pre-Arrival Support
- Medical Record Review: Review of your pathology reports, genetic testing results, imaging, and staging workup
- Virtual Consultation: Video consultation with Professor Shen's team to discuss your diagnosis, genetic risk, and surgical options
- MDT Review: Arrangement of multidisciplinary team review of your case
- Genetic Counseling Coordination: Arrangement of genetic counseling and BRCA testing if not yet performed
- Treatment Planning: Personalized surgical plan including procedure type, reconstruction options, and risk-reduction strategies
- Cost Transparency: Detailed cost estimate including consultations, surgery, and hospitalization
- Visa Assistance: Medical visa guidance and invitation letters
- Travel Arrangements: Flights, airport pickup, and accommodation near the hospital
During Treatment
- Professional Medical Interpretation: Experienced oncology interpreters at all appointments
- Hospital Navigation Support: Registration, payment, and hospital navigation assistance
- Surgical Support: Accompaniment and family support on surgery day
- 24/7 Support: Round-the-clock assistance for any concerns
Post-Treatment Care
- Pathology Report Translation: Complete translation of surgical pathology and molecular profiling reports
- Treatment Summary: Comprehensive oncology summary for your home oncologist and breast surgeon
- Genetic Report Translation: Translation of genetic testing results and risk management recommendations
- Adjuvant Therapy Coordination: Guidance on recommended chemotherapy, radiation, hormonal therapy, or targeted therapy
- Telemedicine Follow-up: Virtual follow-up with Professor Shen's team
- Long-term Support: Ongoing assistance for surveillance and follow-up
Schedule Your Consultation
If you or a loved one has been diagnosed with breast cancer, carries a BRCA mutation, or has a strong family history of breast cancer, Professor Shen Kunwei at Fudan University Shanghai Cancer Center offers world-class breast cancer surgical expertise at a fraction of Western costs.
Contact China Medical Concierge - Shanghai today to request a pathology and imaging review, schedule a virtual consultation, and begin planning your journey to Shanghai for expert breast cancer surgery.
Bridging international patients with Shanghai's finest breast cancer surgeons — because every patient deserves personalized, expert breast cancer care.
0 comments